Ligand Pharma (LGND) PT Lifted to $127 at Roth Capital Following Q1 and as Pipeline Expands
Go back to Ligand Pharma (LGND) PT Lifted to $127 at Roth Capital Following Q1 and as Pipeline Expands| LIGAND PHARMA (NASDAQ: LGND) | Delayed: 278.50 +16.33 (6.23%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $262.17 | 52 Week High | $139.79 | |||
| Open | $259.35 | 52 Week Low | $82.07 | |||
| Day High | $278.78 | P/E | 647.67 | |||
| Day Low | $258.00 | EPS | $0.43 | |||
| Volume | 1,826,683 | |||||
